synthetic DNA-based therapeutics and innovative medicines for serious illnesses
home
about us
synthetic biologics
funded clinical programs
multiple sclerosis
fibromyalgia
ALS
scientific publications
glossary
investors
contact us
funded clinical programs
Print
Email
forward-looking statements
© Synthetic Biologics, Inc. 2012